Cointime

Cimeio Therapeutics

company

About

Cimeio Therapeutics develops curative treatments for genetic diseases, hematologic malignancies, and severe autoimmune disorders.

  • 11 - 50

Highlights

Total Funding Amount
$50M
Funding Rounds
1
Investors
1
Investments
2

Details

Last Funding Type
Series A
Last Funding Money Raised
$50M
Industries
Biopharma,Biotechnology,Health Care,Medical
Founded date
Jan 1, 2020
Number Of Employee
11 - 50
Operating Status
Active

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$50M
Cimeio Therapeutics has raised a total of $50M in funding over 2 rounds. Their latest funding was raised on Apr 13, 2022 from a Series A round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Apr 13, 2022 Series A $50M 1 Versant Ventures — Detail

Investments

Number of Investments
Number of Lead Investments
2
0
Cimeio Therapeutics has made 2 investments. Their most recent investment was on Oct 12, 2021, when FrankieOne raised $20M.
Date Company Name
Round Money Raised Industry Lead Investor
Oct 12, 2021 FrankieOne
Series A $20M Developer APIs —
Jul 28, 2021 Quansa
Seed $3.58M Employee Benefits —

Investors

Number of Lead Investors
Number of Investors
1
1
Cimeio Therapeutics is funded by 1 investors. Versant Ventures are the most recent investors.
Investor Name Lead Investor Funding Round
Versant Ventures Yes Series A
Cointime
เนื้อหา
บริษัท